Mirinda Ann Gormley
Biographic Data
| ID | 6082321 |
|---|---|
| NAME | Mirinda Ann Gormley |
| GIVEN NAMES | Mirinda Ann |
| FAMILY NAME | Gormley |
| SIGNATURE | GORMLEY M A |
| AFFILIATIONS | Jamila Johnson, Carrie Baldwin, Michelle Bublitz, Smith F. Heavner, Prerana Roth, and Alain H. Litwin are with the Addiction Research Center, Prisma Health, Greenville, SC. Mirinda Ann Gormley is with the Department of Public Health Services, Clemson University, Clemson, SC. Susanne Bentley is with the Department of Medicine, University of South Carolina School of Medicine, Greenville. |
| ORCID | 0000-0002-8158-7055 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
HIV Preexposure Prophylaxis Care Continuum Among Individuals Receiving Medication for Opioid Use Disorder, South Carolina, 2020–2021
We implemented the HIV preexposure prophylaxis (PrEP) care continuum among individuals receiving medication for opioid use disorder (MOUD). We screened HIV-negative MOUD participants for PrEP eligibility by assessing injection drug use risk factors and sexual behaviors. Implementation of the PrEP care continuum was challenging; less than a third of MOUD participants were aware of PrEP, and very few initiated PrEP. Findings should promote the deve…
HIV Preexposure Prophylaxis Care Continuum Among Individuals Receiving Medication for Opioid Use Disorder, South Carolina, 2020–2021
We implemented the HIV preexposure prophylaxis (PrEP) care continuum among individuals receiving medication for opioid use disorder (MOUD). We screened HIV-negative MOUD participants for PrEP eligibility by assessing injection drug use risk factors and sexual behaviors. Implementation of the PrEP care continuum was challenging; less than a third of MOUD participants were aware of PrEP, and very few initiated PrEP. Findings should promote the deve…
HIV Preexposure Prophylaxis Care Continuum Among Individuals Receiving Medication for Opioid Use Disorder, South Carolina, 2020–2021
We implemented the HIV preexposure prophylaxis (PrEP) care continuum among individuals receiving medication for opioid use disorder (MOUD). We screened HIV-negative MOUD participants for PrEP eligibility by assessing injection drug use risk factors and sexual behaviors. Implementation of the PrEP care continuum was challenging; less than a third of MOUD participants were aware of PrEP, and very few initiated PrEP. Findings should promote the deve…
Continuum of care (1 work) · Family medicine (1 work) · Health care (1 work) · HIV, Drug Use, Sexual Risk (1 work) · HIV/AIDS Research and Interventions (1 work) · Human immunodeficiency virus (HIV) (1 work) · Internal Medicine (1 work) · Internal Medicine (1 work) · Medication adherence (1 work) · Medicine (1 work)